Researchers Identify New Strategy to Fight Cancer With Minimum Side Effects
Penn State University researchers have come up with a promising cancer-fighting strategy for 'reactivating' genes that cause cancer tumors to shrink and die.
Penn State University researchers have come up with a promising cancer-fighting strategy for 'reactivating' genes that cause cancer tumors to shrink and die.
The reports come directly from the European Union's medicines safety database, called EudraVigilance.
The information comes from reports of adverse reactions submitted by patients and doctors to national regulatory authorities, as well as by pharmaceutical companies, which are legally required to do this to gain a licence to sell a drug in the EU.
Clinical Trial Finds New Prostate Cancer Therapy Effective With Fewer Side Effects
Researchers said Tuesday a new prostate cancer treatment using high frequency sound waves may be a suitable alternative to surgery and radiotherapy with less chance of incontinence or impotence.
Researchers said Tuesday a new prostate cancer treatment using high frequency sound waves may be a suitable alternative to surgery and radiotherapy with less chance of incontinence or impotence.
"Suspected side effects may not be related to or caused by the medicine, and as a result, the published information cannot be used to determine the likelihood of experiencing a side effect or as an indication that a medicine is harmful," it cautioned.
Advertisement
Recent Study Provides Insight into Magnetic Resonance Imaging Side Effects
Researchers in a recent study say that great care should be taken when preforming magnetic resonance imaging in patients with cardiac pacemaker.
Researchers in a recent study say that great care should be taken when preforming magnetic resonance imaging in patients with cardiac pacemaker.
Source-AFP
FDA Links Merck's Drugs to Sexual Side Effects
Two Merck drugs for treating male baldness and enlarged prostate will now carry extended labels to add more possible sexual side effects, US regulators said.
Two Merck drugs for treating male baldness and enlarged prostate will now carry extended labels to add more possible sexual side effects, US regulators said.
